Taiwanese Pharmaceuticals & Biotech High And Sustainable

Results

0 new

Companies in a sound financial shape with a dividend yield of more than 5%.

3 companies

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

8432

NT$50.50

3.7%

TTY Biopharm

Market Cap: NT$19.5b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

4105

NT$78.40

3.0%

2.6%

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

1777

NT$74.10

-0.5%

-1.7%